Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
Ultragenyx Pharmaceutical Inc. (RARE)
Today's Latest Price: $44.43 USD
0.11 (0.25%)
Updated Mar 31 6:55pm
Add RARE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RARE Stock Summary
- For RARE, its debt to operating expenses ratio is greater than that reported by merely 10.73% of US equities we're observing.
- RARE's price/sales ratio is 23.16; that's higher than the P/S ratio of 95.38% of US stocks.
- As for revenue growth, note that RARE's revenue has grown 101.41% over the past 12 months; that beats the revenue growth of 94.42% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Ultragenyx Pharmaceutical Inc are RGNX, ASMB, FPRX, MEIP, and PZG.
- Visit RARE's SEC page to see the company's official filings. To visit the company's web site, go to www.ultragenyx.com.
RARE Daily Price Range
RARE 52-Week Price Range
RARE Stock Price Chart More Charts
RARE Price/Volume Stats
| Current price | $44.43 | 52-week high | $74.50 |
| Prev. close | $44.32 | 52-week low | $31.99 |
| Day low | $42.57 | Volume | 483,800 |
| Day high | $44.88 | Avg. volume | 585,679 |
| 50-day MA | $52.02 | Dividend yield | N/A |
| 200-day MA | $49.77 | Market Cap | 2.57B |
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
Top Stories View All
Best & Worst Performing Stock Industries for March 31, 2020
Best & Worst Performing Small Cap Stocks for March 31, 2020
Best & Worst Performing Mid Cap Stocks for March 31, 2020
Best & Worst Performing Large Cap Stocks for March 31, 2020
Best & Worst Performing Mega Cap Stocks for March 31, 2020
View All Top Stories
Loading social stream, please wait...